Switching from dulaglutide to tirzepatide boosts patient-reported well-being for people with type 2 diabetes: Analysis

An analysis of patient-reported outcomes (PROs) from the SURPASS-SWITCH trial found that adults with type 2 diabetes who switched from dulaglutide to tirzepatide not only saw stronger improvements in blood sugar and weight but also reported…

Continue Reading

News Source: medicalxpress.com